Ask AI
VERONA Subgroup Analyses
VERONA: Subgroup Analyses of Venetoclax or Placebo Combined With Azacitidine in Treatment-Naive Higher-Risk MDS

Released: December 10, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 10, 2025